Table of Contents
Healthy diagnosis: Increasing access to healthcare coverage will improve industry revenue
Specialist Doctors in the US
In recent years, the Specialist Doctors industry benefited from a rise in demand for its services, due to an aging population and the growing prevalence of chronic diseases. Moreover, industry growth was aided by improving access to healthcare insurance as a result of the Patient Protection and Affordable Care Act (PPACA). As a result, industry revenue is projected to grow over the five years to 2016, as healthcare reform enters its third year of full implementation. However, the effects of healthcare reform have ultimately proven to be mixed for the industry. With its emphasis on primary care, the PPACA has begun to move reimbursement under Medicare and Medicaid away from the traditional fee-for-service model. While key growth drivers, including income levels and private health insurance rates, are forecast to improve over the next five years, profit growth is expected to be stagnant over the next five years as specialist doctors bear the brunt of the PPACA's cost-cutting reforms. Nonetheless, demand for industry services will remain strong as a result of positive demographic changes and rising access to healthcare coverage, both private and public.
A specialist doctor is a physician whose practice is limited to a particular branch of medicine or surgery. This industry includes establishments or health practitioners with a doctor of medicine or doctor of osteopathy degree. These individuals primarily practice specialized medicine, such as anesthesiology; oncology and ophthalmology; or surgery. This industry does not include primary care physicians or mental health specialists.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Primary Care Doctors in the US
Emergency & Other Outpatient Care Centers in the US
Specialist Medical Services in Australia
Global Pharmaceuticals & Medicine Manufacturing
Pharmaceutical Manufacturing in China
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...
PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...
OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 Summary Diabetic Foot Ulcer (DFU) and Diabetic Foot Infection (DFI) market is set to triple in value from $292.1 Million ...